[ad_1]
BioNTech founder and director Ugur Sahin says that the launch of the COVID-19 vaccine in December this year is possible, announced AFP on Twitter. The authorization request will be submitted tomorrow in the United States and next week in Europe, he said.
BioNTech and Pfizer have announced this week that the collaboratively developed vaccine was a success in the testing phases, demonstrating an efficiency of 95%.
„We work at maximum speed “, a he said, confirming that the two companies intends to request an emergency use authorization vaccine in the US on Friday, while European regulators will receive a set data from “next week”.
„There is a possibility that this year we will receive approval from the US, Europe, or both. Putem even begins administering the vaccine in December, if everyone working very tight”, he said.
Sahin announced yesterday that BioNTech is working on an improved formula for its vaccine, which will allow it to be transported at room temperature.
In the present, Vaccine transportation and storage conditions are difficult to meet: the product must be kept at -75 degrees Celsius, 50 degrees cooler than any other vaccine currently used in the US. Medical offices, pharmacies, and state laboratories do not They have freezers that reach such low temperatures.
Editing: Monica Bonea
